Antimony Resources: Central Zone Assays Set to Test Market Skepticism at Bald Hill

Antimony Resources stock falls 14% as market awaits Central Zone assay results; analysts see 400% upside to C$3 target amid high-grade antimony intercepts.

Investors in Antimony Resources are bracing for what could be a make-or-break session this week as assay results from the Central Zone at the Bald Hill project in New Brunswick remain in the pipeline. The stock has shed 14.42 percent over the past seven trading days, a slide that has come despite the company reporting drill intercepts of up to 33.40 percent antimony from the Main Zone earlier this month. The disconnect between strong geology and weakening price action has left the market in a wait-and-see posture.

The shares closed Friday at EUR 0.37, down 3.66 percent on the day. That leaves the equity off 9.80 percent on the month, though it still carries a year-to-date gain of 12.75 percent and a remarkable 379.17 percent increase over the past twelve months. Analysts at GBC AG, who rate the stock a Buy with an unchanged target of C$3.00 (EUR 1.85), argue that the underlying exploration story remains compelling. They point to multiple high-grade stibnite intervals, including sections grading as high as 36.0 percent antimony, as evidence that geological risk is gradually being retired. Yet the gulf between that target and the current price — a roughly 400 percent upside — underscores just how much execution risk the market is currently pricing in.

A likely contributor to the recent softness is a share overhang of 21 million new units, which has added supply pressure in a thinly traded name. On the technical side, the stock now sits below both the 50-day moving average of EUR 0.46 and the 200-day average of EUR 0.47, while the 100-day average stands at EUR 0.59. The 14-day relative strength index reads 41.2, a neutral-to-slightly-bearish reading that has not yet dipped into oversold territory. With annualized 30-day volatility at 100.75 percent, the shares remain among the most volatile listings in the Canadian junior mining space, leaving them prone to sharp reversals on fresh news.

The drilling program that has sparked so much attention extends for 18,000 meters across Bald Hill’s Main Zone, where the latest results included the standout 33.40 percent antimony intersection, as well as exploration in the so-called New Zones. More than 2,000 meters have already been completed in the Central Zone, and samples from the first batches are now being processed at Actlabs. Management has indicated results would be released three to four weeks after the end of June, meaning a data package could arrive as early as the current trading week. A formal NI 43-101 resource estimate is expected in the third quarter; for now, a technical report defines an exploration target ranging from 69,994 to 92,782 tonnes of antimony at 3.0 percent Sb, or alternatively from 93,325 to 123,711 tonnes at 4.0 percent Sb.

The broader antimony market provides a supportive backdrop for any Western explorer that can demonstrate progress toward production. China has suspended its export ban on civilian-use antimony until November 2026, but strict licensing requirements remain in place alongside a permanent embargo on military applications. That regulatory complexity, combined with prices that have surged toward USD 60,000 per tonne, has sharpened the focus on potential non-Chinese sources. Bald Hill’s location in New Brunswick positions it as a North American alternative, a narrative that has helped sustain investor interest despite the recent price slide.

Looking ahead, the EUR 0.37 level will be closely watched as near-term support. If the Central Zone assays confirm continuity and grade similar to the Main Zone, a move back above the 200-day line at EUR 0.47 becomes plausible. Should the results disappoint, the stock could revisit its 52-week low of EUR 0.07 from July 2025 — though the 399 percent cushion from that level offers some psychological reassurance. With volatility this high, the next few days are expected to deliver a definitive signal on whether the market’s skepticism is justified or simply a prelude to another explosive leg higher.